4//SEC Filing
Aguilar Laura K. 4
Accession 0000899243-21-031088
CIK 0001841387other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 8:04 PM ET
Size
13.2 KB
Accession
0000899243-21-031088
Insider Transaction Report
Form 4
Aguilar Laura K.
10% Owner
Transactions
- Conversion
Series B Preferred Stock
2021-07-29−137,881→ 0 total→ Common Stock (56,096 underlying) - Conversion
Common Stock
2021-07-29+56,096→ 931,039 total
Holdings
- 2,013,100(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.
- [F2]Includes 32,399 shares of common stock held jointly with spouse.
- [F3]Shares held by the Laura K. Aguilar 2020 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, if any.
Issuer
Candel Therapeutics, Inc.
CIK 0001841387
Entity typeother
Related Parties
1- filerCIK 0001873915
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 8:04 PM ET
- Size
- 13.2 KB